Re-Vana Therapeutics
Peter McKenna is a skilled research scientist currently employed at Re-Vana Therapeutics, where a recent promotion to Project Lead occurred in January 2024. With a diverse background in pharmacy, Peter has worked as a locum pharmacist since July 2018 and has held positions including Research Fellow at the School of Pharmacy at Queen's University Belfast and Pre-registration Pharmacist at MediCare Pharmacy Group (NI). Peter's academic achievements include a PhD in Pharmaceutical Sciences and a Master's degree in Pharmacy, both obtained from Queen's University Belfast. Prior experience includes roles as a Dispensary Technician and Retail Sales Assistant at Torrent Pharmacy.
Re-Vana Therapeutics
Re-Vana Therapeutics is an ocular pharmaceutical and drug delivery company focused on the development and commercialisation of revolutionary long-acting biodegradable drug delivery platforms to treat chronic eye diseases such as age-related macular degeneration, diabetic retinopathy, glaucoma and ocular infections.